The Fluorescene Show Episode 24

Описание к видео The Fluorescene Show Episode 24

The Fluorescene Show is the eye care industry’s first late-night talk show with interviews and more.

In Episode 24, we welcome optometric legend Dr. Murray Fingeret, Professor at SUNY Optometry, co-founder and past President of the Optometric Glaucoma Society, and 2019 inductee in the National Optometry Hall of Fame.

We have a new episode of Dr. Mile Brujic and Dr. David Kading’s “Clinical Insights from Optometric Insights,” and our INTERACTIVE segment "Compelling Clinical Images of the Week on ODs on Facebook," in which we share compelling clinical images posted in the community from the past week. Scan the QR code in each image which will take you to the conversation thread in "ODs on Facebook," and you can share your knowledge or learn more! You must be a member first, so if you're not, be sure to request to join the "ODs on Facebook" community and answer all three questions fully.

We air "This Week in Eye Care Research News" and more!

0:20 Welcome from Dr. Glazier
0:36 ODs on Facebook Group Highlights Commentary
2:20 Guest Introductions – Dr. Alan Glazier
3:08 Compelling Clinical Images of the Week on ODs on Facebook
5:36 Compelling Clinician’s Corner – Dr. Murray Fingeret, Optometrist
45:45 Eye Care Industry News
45:56 Diabetes news – The Singapore National Eye Centre assessed the risk of cataract surgery in patients with type 2 diabetes mellitus
46:28 Therapeutic eye drop news – Santen announced that the US FDA approved Verkazia (cyclosporine ophthalmic emulsion) 0.1% eye drops to treat vernal keratoconjunctivitis
47:11 Retinal news – Data presented as a late-breaking poster at the 2021 American Diabetes Association Virtual Meeting, researchers assessed the link between the use of sodium-glucose cotransporter-2 or SGLT2 inhibitors and retinal vein occlusion
47:47 Retinal gene therapy news – RGX-314 uses an adeno-associated viral 8 vector to deliver a gene encoding for a therapeutic anti-VEGF Fab protein and is designed to produce continuous anti-VEGF therapy
48:38 Retinal news – Evaluation of real-world outcomes of anti-VEGF therapy in the primary treatment of choroidal neovascularization secondary to pathological myopia were studied
49:16 More retinal news – Researchers from the Universidad Complutense de Madrid are focusing attention on the roughness of the ten retinal layers as a marker for risk of developing Alzheimer’s Disease
50:03 AMD news – The University of Maryland School of Medicine researchers showed the process which removes the eye’s old, damaged light sensors is disrupted in macular degeneration
51:13 Glaucoma news – A capsanthin ingredient from Unibar Corporation called CapsiClear has been found to support the ocular system’s ability to regulate intraocular pressure
52:01 More glaucoma news – A sublayer of the inner plexiform layer holds promise as a potential biomarker in efforts to detect early glaucomatous changes according to researchers at the Department of Ophthalmology at the New York University Langone Health
52:46 Myopia news – Australian-based researchers have found that bad sleeping patterns are more common amongst those with myopia compared to people with normal eyesight
53:28 Clinical Insights from Optometric Insights – Dr. David Kading & Dr. Mile Brujic

Комментарии

Информация по комментариям в разработке